Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
SciSparc Ltd. - Ordinary Shares
(NQ:
SPRC
)
0.3273
-0.0227 (-6.49%)
Streaming Delayed Price
Updated: 3:06 PM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
125,971
Open
0.3500
Bid (Size)
0.3273 (1)
Ask (Size)
0.3274 (5)
Prev. Close
0.3500
Today's Range
0.3200 - 0.3500
52wk Range
0.3013 - 14.22
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
SciSparc’s Collaboration with Clearmind Medicine Continues to Bear Fruit With New Scientific Article Showing MEAI Potential as a Novel Weight Loss Drug
August 06, 2024
From
SciSparc Ltd
Via
GlobeNewswire
SciSparc: MitoCareX Confirms Potential Significant Role of its Drug Target in Non-Small Cell Lung Cancer
July 22, 2024
From
SciSparc Ltd
Via
GlobeNewswire
Performance
YTD
-93.57%
-93.57%
1 Month
-60.09%
-60.09%
3 Month
-73.82%
-73.82%
6 Month
-90.51%
-90.51%
1 Year
-93.08%
-93.08%
More News
Read More
SciSparc Signs Non-Binding Letter of Intent for Exclusive Global Out-Licensing of Pain Treatment for Approximately $6 million
July 17, 2024
From
SciSparc Ltd
Via
GlobeNewswire
Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 16, 2024
Via
Benzinga
SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification
July 16, 2024
From
SciSparc Ltd
Via
GlobeNewswire
Mizuho Just Issued a Warning on Palantir (PLTR) Stock
July 16, 2024
Via
InvestorPlace
Why Is SciSparc (SPRC) Stock Up 25% Today?
July 16, 2024
Via
InvestorPlace
Topics
Intellectual Property
Exposures
Intellectual Property
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
July 16, 2024
Via
InvestorPlace
SciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight Loss
July 16, 2024
From
SciSparc Ltd
Via
GlobeNewswire
Why WD-40 Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
July 11, 2024
Via
Benzinga
SciSparc Signs Non-Binding Letter of Intent for Spin Off of Advanced Clinical Stage Pharmaceutical Portfolio to Publicly Traded Company
July 08, 2024
From
SciSparc Ltd
Via
GlobeNewswire
SciSparc Secures Strategic Advantage with Grant of European Patent
May 31, 2024
From
SciSparc Ltd
Via
GlobeNewswire
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 16, 2024
Via
Benzinga
Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
April 16, 2024
Via
Benzinga
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 11, 2024
Via
Benzinga
SciSparc To Acquire AutoMax, A Strategic Leap Towards Industry Diversification
April 11, 2024
Via
Benzinga
SciSparc to Acquire AutoMax
April 11, 2024
From
SciSparc Ltd
Via
GlobeNewswire
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
April 11, 2024
Via
Benzinga
SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression
March 27, 2024
From
SciSparc Ltd
Via
GlobeNewswire
SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research
March 21, 2024
From
SciSparc Ltd
Via
GlobeNewswire
SciSparc Granted Another Patent, Strengthening its Core Technology in Canada
March 18, 2024
From
SciSparc Ltd
Via
GlobeNewswire
SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial
March 14, 2024
From
SciSparc Ltd
Via
GlobeNewswire
Podcast: Clearmind's Non-Hallucinogenic Psychoactive Molecule Could Become A Solution For Addictive Behaviors
March 12, 2024
Via
Benzinga
SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure
March 12, 2024
From
SciSparc Ltd
Via
GlobeNewswire
Autism CBD Trial Enrolls Children: This Israeli Co. Is Making Headway In New Treatments
March 08, 2024
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.